Kenneth Research recently added a report on PEGylated Proteins Market in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth opportunities and growth drivers that are associated with the growth of the market. The report additionally shares critical insights on the COVID-19 impacts on the PEGylated Proteins Market along with the compound growth rate (CAGR) of the market for a projected period between 2022 and 2031. The report also includes analysis of the market by utilizing different analytical tools, such as PESTEL analysis and Porter’s five forces analysis. These tools also provide an in-depth analysis on the micro and macro-environmental factors that are associated with the growth of the market during the forecast period.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for PEGylated Proteins Market products.
Request of this Sample Report – https://www.kennethresearch.com/sample-request-10059435
The global PEGylated Proteins Market was valued at USD 690.54 million in 2016 and is projected to reach USD 1686.45 million by 2025, growing at a CAGR of 10.43% from 2017 to 2025.
PEGylation (often styled pegylation) is the process of both covalent and non-covalent attachment or amalgamation of polyethylene glycol polymer chains to molecules and macrostructures, such as a drug, therapeutic protein or vesicle, which is then described as PEGylated (pegylated).
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Growing R&D Spending
1.2 Rising Biologics Sector
1.3 Technological developments in Protein Based Drugs and Non Protein Based drugs
1.4 Growing Protein’s Stability
1.5 Major Lifestyle changes and associated diseases
2. Market Restraints
2.1 Drug Failure and Recalls Hinders Market Growth
Market Segmentation:
1. Global PEGylated Proteins Market, by End User:
1.1 Pharmaceutical & Biotechnology Companies
1.2 Contract Research Organization
1.3 Academic Research Institutes
2. Global PEGylated Proteins Market, by Application:
2.1 Cancer Treatment
2.2 HEPAtitis
2.3 Chronic Kidney Disease
2.4 Hemophilia
2.5 Multiple Sclerosis
2.6 Gastrointestinal Disorder
2.7 Other Application
3. Global PEGylated Proteins Market, by Protein Type:
3.1 Colongy Stimulating Factors
3.2 Interferons
3.3 Erythropoietin (EPO)
3.4 Recombinant Factor Viii
3.5 Monoclonal Antibodies
3.6 Other Protein Type
4. Global PEGylated Proteins Market, by Product:
4.1 Consumables
4.1.1 Pegylation Kits
4.1.2 Pegylation Reagents
4.1.2.1 Monofunctional Linear Pegs
4.1.2.2 Bifunctional Pegs
4.1.2.3 Multi-Arm Pegs
4.1.2.4 Branched Pegs
4.1.2.5 Other Pegylation Reagents
4.2 Services
4.2.1 Development of PEGylated Biosimilars
4.2.2 Process Development of Peg-Drug Conjugate Manufacturing
4.2.3 Pilot Production of Peg Drug Conjugate
4.2.4 Development of Analytical Methods
4.2.5 Pegylation Feasibility Studies
5. Global PEGylated Proteins Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Merck Millipore
2. Thermo Fisher Scientific Inc.
3. NOF American Corporation (A Subsidiary of NOF Corporation)
4. Jenkem Technology
5. Creative Pegworks
6. Celares GmbH
7. Quanta Biodesign, Ltd
8. Biomatrik, Inc.
9. Iris Biotech GmbH
10. Laysan Bio, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH:
Research study on the PEGylated ProteinsMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
Access Full Report Here – https://www.kennethresearch.com/report-details/global-pegylated-proteins-market/10059435
About Us
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research, are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.
Contact Us
Name: Kenneth research
Email:sales@kennethresearch.com
Phone: +1 313 462 0609